Early palliative care for acute myeloid leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study compares starting palliative care early (alongside regular treatment) with receiving standard care only, for people with acute myeloid leukemia. The goal is to see if early palliative support improves quality of life and helps manage symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute myeloid leukemia (AML).
- You are 70 years old or younger.
- You are able to make your own medical decisions.
- You are being treated at the Hematology department of Centro Hospitalar e Universitário de São João.
- You are not receiving only comfort care (also called 'best supportive care').
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding early palliative care to standard chemoradiation helps people with advanced head and neck cancer feel better and live better. It aims to improve quality of life during and after treatment.
This study tests a specialized (targeted) palliative care program versus usual oncology care for people hospitalized with high-risk acute myeloid leukemia (AML). The goal is to see if this palliative approach improves comfort, support, and care planning during intensive treatment.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This trial tests an emotion- and symptom-focused way of engaging with care for people who are newly diagnosed with acute leukemia and starting intensive “induction” treatment aimed at cure. It may help you feel better supported and better able to manage distressing symptoms during a critical early phase of treatment.
This study tests whether adding early palliative care from a specialist improves well-being for people starting treatment for advanced non-small cell lung cancer. It compares standard cancer care alone to standard care plus early palliative care.
This study offers a palliative care team (doctors and nurses focused on comfort and quality of life) to people newly diagnosed with multiple myeloma or with an aggressive lymphoma that has come back. The goal is to help manage symptoms early, so you feel better and stay stronger during your cancer treatment.
Hear when a new Palliative Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.